Final efficacy results from IMpower132: First-line atezolizumab plus chemotherapy in patients with stage IV non-squamous NSCLC
No Thumbnail Available
Identifiers
Date
2020-11-01
Authors
Nishio, M.
Barlesi, F.
Ball, S.
Bordoni, R.
Cobo, M.
Dubray-Longeras, P.
Goldschmidt, J.
Novello, S.
Orlandi, F. J.
Sanborn, R.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
